Last reviewed · How we verify

NAC Bicarbonate — Competitive Intelligence Brief

NAC Bicarbonate (NAC Bicarbonate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant/renal protective agent. Area: Nephrology/Radiology.

marketed Antioxidant/renal protective agent Nephrology/Radiology Small molecule Live · refreshed every 30 min

Target snapshot

NAC Bicarbonate (NAC Bicarbonate) — Seoul National University Hospital. NAC Bicarbonate combines N-acetylcysteine (a mucolytic and antioxidant agent) with sodium bicarbonate to reduce mucus viscosity and neutralize acidic environments in the respiratory tract.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
NAC Bicarbonate TARGET NAC Bicarbonate Seoul National University Hospital marketed Antioxidant/renal protective agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant/renal protective agent class)

  1. Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). NAC Bicarbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/nac-bicarbonate. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: